$8.43 -0.15 (-1.75%)
11/27/2009 1:00 PM

Albany Molecular Research, Inc. (AMRI)

CAPS Rating: 3 out of 5

The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.

Featured Broker Partners